Yashasvi Jaiswal, Shafali Verma receive notices over missed dope tests: Sources

3

Yashasvi Jaiswal and Shafali Verma have been served their first “missed test” notices by the National Anti-Doping Agency (NADA) after allegedly failing to report at their declared locations for scheduled out-of-competition dope tests.

The two cricketers, who are part of NADA’s Registered Testing Pool (RTP), have been asked to explain the circumstances behind the missed tests. The Board of Control for Cricket in India (BCCI) has also been informed about the matter.

Under anti-doping regulations, athletes in the RTP must provide a designated one-hour slot and location where they are available for surprise testing by a Doping Control Officer (DCO). Failure to be present during the declared time period is treated as a whereabouts failure and can result in a “missed test” notice.

According to sources, officials attempted to conduct Jaiswal’s test on December 17 last year, while Shafali’s scheduled test took place on November 7. In both instances, the players were reportedly unavailable at the addresses they had submitted.

NADA later contacted both players in February seeking explanations, but no responses were received within the prescribed timeline, leading to the registration of their first missed tests.

A single missed test does not qualify as an anti-doping rule violation. However, three whereabouts failures — either missed tests or filing lapses — within a 12-month period can trigger disciplinary proceedings under World Anti-Doping Agency rules and may result in a suspension of up to two years.

The development comes during an important phase in both players’ careers. Jaiswal is currently playing for Rajasthan Royals in the ongoing Indian Premier League, while Shafali remains in contention for India’s squad ahead of the Women’s T20 World Cup in England and Wales next month.

The incident has also revived memories of Prithvi Shaw’s 2019 doping case, when the former India opener received an eight-month backdated suspension after testing positive for Terbutaline, a banned substance found in cough syrup.

While the current notices do not amount to doping violations, they serve as a formal warning under NADA’s strict whereabouts compliance framework.

Comments are closed.